Last updated on April 2019

INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists Rivaroxaban or Aspirin Studies Non-Inferiority

Brief description of study

This program is a comprehensive evaluation of rheumatic valvular heart disease (RVHD), Atrial fibrillation (AF)/flutter and stroke.

A prospective, randomized, parallel group, open-label clinical trial of rivaroxaban versus standard vitamin K antagonists (VKA) therapy to evaluate non-inferiority of rivaroxaban to VKA, with testing for superiority if non-inferiority is satisfied.

Clinical Study Identifier: NCT02832544

Find a site near you

Start Over


Chandigarh, India
  Connect »

Clinical Hospital

San Lorenzo, Paraguay
  Connect »

Palawan Medical City

Puerto Princesa City, Philippines
  Connect »

Philippine Heart Center

Quezon City, Philippines
  Connect »

University of Cape Town

Cape Town, South Africa
  Connect »

University of Limpopo

Polokwane, South Africa
  Connect »

Port Elizabeth Hospital Complex

Port Elizabeth, South Africa
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.